Cargando…
Why differentiate low molecular weight heparins for venous thromboembolism?
| Autores principales: | , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2007
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1936420/ https://www.ncbi.nlm.nih.gov/pubmed/17578577 http://dx.doi.org/10.1186/1477-9560-5-8 |
| _version_ | 1782134383760637952 |
|---|---|
| author | Fareed, Jawed Walenga, Jeanine M |
| author_facet | Fareed, Jawed Walenga, Jeanine M |
| author_sort | Fareed, Jawed |
| collection | PubMed |
| description | |
| format | Text |
| id | pubmed-1936420 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2007 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-19364202007-08-01 Why differentiate low molecular weight heparins for venous thromboembolism? Fareed, Jawed Walenga, Jeanine M Thromb J Editorial BioMed Central 2007-06-19 /pmc/articles/PMC1936420/ /pubmed/17578577 http://dx.doi.org/10.1186/1477-9560-5-8 Text en Copyright © 2007 Fareed and Walenga; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Editorial Fareed, Jawed Walenga, Jeanine M Why differentiate low molecular weight heparins for venous thromboembolism? |
| title | Why differentiate low molecular weight heparins for venous thromboembolism? |
| title_full | Why differentiate low molecular weight heparins for venous thromboembolism? |
| title_fullStr | Why differentiate low molecular weight heparins for venous thromboembolism? |
| title_full_unstemmed | Why differentiate low molecular weight heparins for venous thromboembolism? |
| title_short | Why differentiate low molecular weight heparins for venous thromboembolism? |
| title_sort | why differentiate low molecular weight heparins for venous thromboembolism? |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1936420/ https://www.ncbi.nlm.nih.gov/pubmed/17578577 http://dx.doi.org/10.1186/1477-9560-5-8 |
| work_keys_str_mv | AT fareedjawed whydifferentiatelowmolecularweightheparinsforvenousthromboembolism AT walengajeaninem whydifferentiatelowmolecularweightheparinsforvenousthromboembolism |